SCHEMBL4176300

SCHEMBL4176300

CNCCCc1cccc(Oc2ccccc2C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
CHRM3 P20309 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
FFAR1 O14842 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.45
SIGMAR1 Q99720 1/20 0.44
HRH1 P35367 1/20 0.43
MTNR1A P48039 1/20 0.43
MTNR1B P49286 1/20 0.43
TP53 P04637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
FDFT1 P37268 3/20 0.42
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1950248 0.99 MEN1 (0.51) CHRM2CHRM1CHRM3MEN1KMT2A
SCHEMBL5033743 0.81 FFAR1 (0.48) FFAR1SIGMAR1HRH1FDFT1NOS3
SCHEMBL6267704 0.77 CHRM2 (0.81) CHRM2CHRM1CHRM3MEN1KMT2A
SCHEMBL922401 0.76 FFAR1 (0.51) MEN1KMT2AFFAR1CYP1A2CYP2C9
SCHEMBL1745696 0.76 FFAR1 (0.54) MEN1KMT2AFFAR1TSHR
SCHEMBL25819935 0.75 MEN1 (0.62) CHRM2CHRM1CHRM3MEN1KMT2A
SCHEMBL11464993 0.75 BCHE (0.68) CHRM2CHRM1CHRM3MEN1KMT2A
SCHEMBL28685138 0.75 TAAR1 (0.50) MEN1KMT2AFFAR1SIGMAR1KDM4E
SCHEMBL28691269 0.75 TAAR1 (0.50) MEN1KMT2AFFAR1SIGMAR1KDM4E
SCHEMBL27778111 0.75 TAAR1 (0.50) MEN1KMT2AFFAR1SIGMAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082597-A1 PROCESS FOR PREPARING A COMPOUND FERMION OY (FI) 2009-03-26 US disclosed
WO-2007010082-A1 PROCESS FOR PREPARING A 3-ARYLOXY-3-ARYLPROPYLAMINE FERMION OY (FI) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082597-A1 PROCESS FOR PREPARING A COMPOUND AOC3, TYR, ADH1C CHRM2 2058/4885CHRM1 1441/4885CHRM3 1344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.